Erika Trahan | Associate Director, Investor Relations and Public Relations |
Stan Erck | President and CEO |
John Trizzino | Chief Business Officer and CFO |
Gregory Glenn | President of Research and Development |
Michael Higgins | Ladenburg Thalmann |
Vernon Bernardino | H.C. Wainwright |
Mayank Mamtani | B. Riley |
Ladies and gentlemen, thank you for standing by, and welcome to the Novavax First Quarter 2020 Financial Results Conference Call. [Operator Instructions]
It is now my pleasure to introduce Associate Director of IR-PR, Erika Trahan.
Thank you, Operator. Good afternoon and thank you to everyone who has joined today's call to discuss our first quarter 2020 operational highlights and financial results.